BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16259778)

  • 1. Distribution of sigma receptors in EMT-6 cells: preliminary biological evaluation of PB167 and potential for in-vivo PET.
    Colabufo NA; Berardi F; Contino M; Fazio F; Matarrese M; Moresco RM; Niso M; Perrone R; Tortorella V
    J Pharm Pharmacol; 2005 Nov; 57(11):1453-9. PubMed ID: 16259778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors.
    Kassiou M; Dannals RF; Liu X; Wong DF; Ravert HT; Scheffel UA
    Bioorg Med Chem; 2005 Jun; 13(11):3623-6. PubMed ID: 15862990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).
    Berardi F; Abate C; Ferorelli S; Uricchio V; Colabufo NA; Niso M; Perrone R
    J Med Chem; 2009 Dec; 52(23):7817-28. PubMed ID: 19842660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer.
    Mach RH; Smith CR; al-Nabulsi I; Whirrett BR; Childers SR; Wheeler KT
    Cancer Res; 1997 Jan; 57(1):156-61. PubMed ID: 8988058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogues of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with added polar functionality and reduced lipophilicity for potential use as positron emission tomography radiotracers.
    Abate C; Niso M; Lacivita E; Mosier PD; Toscano A; Perrone R
    J Med Chem; 2011 Feb; 54(4):1022-32. PubMed ID: 21229979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
    Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
    Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.
    Berardi F; Ferorelli S; Abate C; Colabufo NA; Contino M; Perrone R; Tortorella V
    J Med Chem; 2004 Apr; 47(9):2308-17. PubMed ID: 15084129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tritium radiolabelling of PB28, a potent sigma-2 receptor ligand: pharmacokinetic and pharmacodynamic characterization.
    Colabufo NA; Abate C; Contino M; Inglese C; Ferorelli S; Berardi F; Perrone R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2183-7. PubMed ID: 18178434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies.
    Matsumoto RR; Potelleret FH; Mack A; Pouw B; Zhang Y; Bowen WD
    Pharmacol Biochem Behav; 2004 Apr; 77(4):775-81. PubMed ID: 15099923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F281, synthetic agonist of the sigma-2 receptor, induces Ca2+ efflux from the endoplasmic reticulum and mitochondria in SK-N-SH cells.
    Cassano G; Gasparre G; Niso M; Contino M; Scalera V; Colabufo NA
    Cell Calcium; 2009 Apr; 45(4):340-5. PubMed ID: 19187959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
    Selivanova SV; Toscano A; Abate C; Berardi F; Müller A; Krämer SD; Schibli R; Ametamey SM
    Nucl Med Biol; 2015 Apr; 42(4):399-405. PubMed ID: 25637276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategy for development of imaging biomarkers].
    Ishiwata K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity.
    Mésangeau C; Narayanan S; Green AM; Shaikh J; Kaushal N; Viard E; Xu YT; Fishback JA; Poupaert JH; Matsumoto RR; McCurdy CR
    J Med Chem; 2008 Mar; 51(5):1482-6. PubMed ID: 18278854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylamides hybrids of two high-affinity σ2 receptor ligands as tools for the development of PET radiotracers.
    Abate C; Ferorelli S; Contino M; Marottoli R; Colabufo NA; Perrone R; Berardi F
    Eur J Med Chem; 2011 Sep; 46(9):4733-41. PubMed ID: 21684636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Cyclohexyl-4-(4-arylcyclohexyl)piperazines: Mixed σ and human Δ(8)-Δ(7) sterol isomerase ligands with antiproliferative and P-glycoprotein inhibitory activity.
    Abate C; Niso M; Contino M; Colabufo NA; Ferorelli S; Perrone R; Berardi F
    ChemMedChem; 2011 Jan; 6(1):73-80. PubMed ID: 21069657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
    Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
    Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands.
    van Waarde A; Rybczynska AA; Ramakrishnan N; Ishiwata K; Elsinga PH; Dierckx RA
    Curr Pharm Des; 2010; 16(31):3519-37. PubMed ID: 21050178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity.
    Berardi F; Abate C; Ferorelli S; de Robertis AF; Leopoldo M; Colabufo NA; Niso M; Perrone R
    J Med Chem; 2008 Dec; 51(23):7523-31. PubMed ID: 19053780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their sigma receptor affinity and cytotoxic activity.
    Holl R; Schepmann D; Grünert R; Bednarski PJ; Wünsch B
    Bioorg Med Chem; 2009 Jan; 17(2):777-93. PubMed ID: 19081725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.